DENELSKY STEPHEN J
SEC Form 4 insider trading activity
DENELSKY STEPHEN J has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, DENELSKY STEPHEN J is listed as Director at HARVARD BIOSCIENCE INC. Inside the rolling window, DENELSKY STEPHEN J reported 1 open-market purchase totaling $49K in HBIO and no open-market sales.
Companies traded
Other insiders at HBIO
Insider Buying
$49K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DENELSKY STEPHEN J made?
DENELSKY STEPHEN J has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does DENELSKY STEPHEN J trade?
DENELSKY STEPHEN J has filed SEC Form 4 disclosures for 1 company, including HBIO.
When was DENELSKY STEPHEN J's most recent SEC Form 4 filing?
DENELSKY STEPHEN J's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is DENELSKY STEPHEN J's total buy and sell value in the current window?
Inside the rolling retention window, DENELSKY STEPHEN J bought $49K and sold $0 based on SEC Form 4 filings.
What was DENELSKY STEPHEN J's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 HBIO shares on 2026-03-17, worth $49K, per SEC Form 4 filings.